News & Events

Gabor Egervari, MD, PhD, has received his first R01 grant from the National Institutes of Health (NIH) to investigate how metabolites of alcohol alter gene regulation in the brain and contribute to behaviors associated with alcohol use disorder.

Guoyan Zhao, an associate professor of genetics and of neurology at Washington University School of Medicine in St. Louis, died Friday, May 15, 2026. She was 53. Zhao was highly regarded for harnessing the tools of computational biology, genomic sequencing and single-cell analysis to shed light on neurological and neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and chronic pain.

WashU Medicine researchers identified key details in how DNA damage can flip a nerve cell’s self-destruct switch. The new study could lead to novel routes to preventing neurodegeneration in a variety of diseases.

Frederick “Eric” Arnold, PhD, an assistant professor of Genetics and collaborators from the University of Idaho have been selected to receive a £100,000 Discovery Award through the Longitude Prize on ALS, an international initiative focused on accelerating the discovery of new treatments for amyotrophic lateral sclerosis (ALS) using artificial intelligence.

Researchers at WashU Medicine and collaborating institutions have developed a novel computational tool that can accurately identify a genetic problem in a gene called RFC1 that is linked to certain forms of peripheral neuropathy. Peripheral neuropathy is one of the most common neurological disorders and can cause pain, sensory loss, imbalance and weakness. It affects 12–20% of all people in the U.S. and can affect up to 30% of adults over age 65. The new research is published in Annals of Neurology.